UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000039803
Receipt No. R000045395
Scientific Title Special Drug Use Surveillance of Alecensa Capsules in Pediatric Patients- Recurrent or refractory ALK fusion gene-positive anaplastic large cell lymphoma -
Date of disclosure of the study information 2020/08/03
Last modified on 2020/09/04 09:38:33

No. Disposal Last modified on Item of update
1 Insert 2020/03/13 07:37:11
2 Update 2020/03/13 09:01:34 Key exclusion criteria
Key exclusion criteria
3 Update 2020/07/17 09:28:36 Date of disclosure of the study information
4 Update 2020/07/17 09:29:35 Anticipated trial start date
5 Update 2020/08/03 14:33:15 Recruitment status
Date of IRB
6 Update 2020/09/04 09:36:51 Anticipated trial start date
7 Update 2020/09/04 09:38:33 Anticipated trial start date

Contact us.